1. MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39
   Rende Guo et al, 2017, BioMed Research International CrossRef
2. MicroRNAs: novel players in cancer diagnosis and therapies.
   Aaron L. Oom et al, 2014, Biomed Res Int CrossRef
3. null
   Katrien Van Roosbroeck et al, 2017 CrossRef
4. New targeted therapies in pancreatic cancer
   Andrada Seicean, 2015, WJG CrossRef
5. Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma
   L. E. A. Delsin et al, 2017, Pathol. Oncol. Res. CrossRef
6. Roles of microRNA-146a and microRNA-181b in regulating the secretion of tumor necrosis factor-α and interleukin-1β in silicon dioxide-induced NR8383 rat macrophages
   YANG ZHANG et al, 2015 CrossRef
7. Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)
   RAMADEVI SUBRAMANI et al, 2015 CrossRef
8. Construction and analysis of three networks of genes and microRNAs in adenocarcinoma
   JIAHUI NING et al, 2015 CrossRef
9. MicroRNA-181b is downregulated in non-small cell lung cancer and inhibits cell motility by directly targeting HMGB1
   Yun Liu et al, 2016 CrossRef
10. miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA
    Qing-An Zhang et al, 2018, CBM CrossRef
11. Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes
    Nicole Ludwig et al, 2016, IJMS CrossRef
12. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
    Guodong Liu et al, 2018, Biomed Pharmacother CrossRef
13. Dysregulation of key microRNAs in pancreatic cancer development
    Behzad Baradaran et al, 2019, Biomedicine & Pharmacotherapy CrossRef
14. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2
    Xiyue Zhang et al, 2019, Biomedicine & Pharmacotherapy CrossRef
15. miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma
    Anteneh A. Tesfaye et al, 2019, The American Journal of Pathology CrossRef
16. Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype
    Mirna Swayden et al, 2018, Heliyon CrossRef
17. Extracellular and intracellular microRNAs in pancreatic cancer: from early diagnosis to reducing chemoresistance
    Xiaohong Jiang et al, 2019, ExRNA CrossRef
18. MicroRNA in pancreatic cancer.
    Keiichi Yonemori et al, 0 CrossRef
19. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Junquan Yang et al, 2013, Pathol. Res. Pract. CrossRef
20. Involvement of microRNA-181b in the gemcitabine resistance of pancreatic cancer cells
    Daisuke Takiuchi et al, 2013, Pancreatology CrossRef
21. miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells.
    Lei Yang et al, 2014, FEBS Lett. CrossRef
22. miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells
    Xiaoling She et al, 2014, Med Oncol CrossRef
23. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
    Mao Ouyang et al, 2014, PLoS ONE CrossRef
24. Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction
    Austin R. Jackson et al, 2014, PLoS ONE CrossRef
25. Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications
    Tao Sun et al, 2014, Gastroenterology Research and Practice CrossRef
26. MiR-181b-5p Downregulates NOVA1 to Suppress Proliferation, Migration and Invasion and Promote Apoptosis in Astrocytoma
    Feng Zhi et al, 2014, PLoS ONE CrossRef
27. miRNAs in pancreatic cancer: Therapeutic potential, delivery challenges and strategies
    Deepak Chitkara et al, 2015, Advanced Drug Delivery Reviews CrossRef
28. MicroRNA Signaling Pathway Network in Pancreatic Ductal Adenocarcinoma.
    Longhao Sun et al, 0 CrossRef
29. Developments in miRNA gene signaling pathways in pancreatic cancer
    Christina Vorvis et al, 2016, Future Oncology CrossRef
30. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer
    Guangbing Xiong et al, 2017, Cancer Letters CrossRef
31. miR‐181b/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation
    Ziwei Han et al, 2019, J Cell Biochem CrossRef
32. microRNA-181 serves as a dual-role regulator in the development of human cancers
    Tayebeh Rezaei et al, 2019, Free Radical Biology and Medicine CrossRef
33. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
    Junjie Xiong et al, 2017, Oncotarget CrossRef
34. MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis
    Mei-Juan Tu et al, 2016, Oncotarget CrossRef
35. Crosstalk between miRNAs and Signaling Pathways Involved in Pancreatic Cancer and Pancreatic Ductal Adenocarcinoma
    Ziba Lotfi et al, 2021, European Journal of Pharmacology CrossRef
36. Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy
    Maria Mortoglou et al, 2021, Translational Oncology CrossRef
37. Circulating miRNA Expression Profiles and Machine Learning Models in Association with Response to Irinotecan-Based Treatment in Metastatic Colorectal Cancer
    Evangelia Pliakou et al, 2022, IJMS CrossRef
38. The expression of miR-155 and miR-181 in gastric cancer and their effects on clinical parameters and prognostic value
    Zhenfeng Shi et al, 2019 CrossRef
39. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells
    Pei Pei Che et al, 2023, International Journal of Radiation Oncology*Biology*Physics CrossRef
40. miRNAs Role in Wilms Tumor Pathogenesis: Signaling Pathways Interplay
    Jaber Alfaifi, 2024, Pathology - Research and Practice CrossRef